STEM CELLS FOR OVARIAN REJUVENATION

OVARIAN REJUVENATION WITH AUTOLOGOUS ADIPOSE DERIVED STEM CELL THERAPY

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202208677419951

Enrollment

Registered

2022-08-10

Start date

2019-09-02

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

stem cell therapy

Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: -Infertility patients with either premature ovarian failure diagnosed clinically and biochemically -Women with very low ovarian reserves diagnosed both biochemically with low AMH and radiologically with low AFC

Exclusion criteria

Exclusion criteria: - history of current or previous malignancy - any other co-existing cause of infertility - inability to visualize the ovaries on transvaginal ultrasound - age >42 years - smoker

Design outcomes

Primary

Measure	Time frame
1)hormonal biomarkers indicating recovery of ovarian function; (a decline in FSH and a rise in AMH) 2)resumption of menstruation in amenorrheic women	—

Secondary

Measure	Time frame
Response to ovarian stimulation with IVF, oocyte quantity obtained, embryo grading, euploidy rates and pregnancy outcomes	—

Countries

South Africa

Contacts

Public ContactTasneem Mohamed

Medical doctor specialist gynaecologist

tm.mohamed@yahoo.com+27725355228

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026